Panelists Stress Stakeholder Education to Build Confidence in Biosimilars
October 31st 2024
ArticleBy expanding educational initiatives to clarify biosimilar safety, efficacy, and interchangeability, stakeholders can foster trust, improve access, and ensure that biosimilars are widely accepted as high-quality, cost-effective alternatives to originator biologics.